University of Helsinki

Terran Orbital’s Milani Satellite Delivered to the European Space Agency for Hera Mission

Retrieved on: 
Tuesday, March 19, 2024
Aerospace, Technology, Manufacturing, Satellite, Telecommunications, Nanotechnology, Networks, Defense, Contracts, Engineering, Mobile, Wireless, INAF, European Space Agency, DART, University of Helsinki, Motivation, University, ESA, International, Travel, Hera, Don Quixote, Tyvak, Science, Geology, Spacecraft, Dust, Australian Space Agency, CubeSat, HERA, VTT, Milani, Brno University of Technology, Mission, Multimedia, Asteroid

Tyvak International SRL (“Tyvak International”), a wholly-owned subsidiary of Terran Orbital Corporation (NYSE: LLAP ) and a leading European nano and microsatellite manufacturer based in Torino, Italy, today announced that they have completed the formal delivery of the Hera Milani satellite to the European Space Agency.

Key Points: 
  • Tyvak International SRL (“Tyvak International”), a wholly-owned subsidiary of Terran Orbital Corporation (NYSE: LLAP ) and a leading European nano and microsatellite manufacturer based in Torino, Italy, today announced that they have completed the formal delivery of the Hera Milani satellite to the European Space Agency.
  • View the full release here: https://www.businesswire.com/news/home/20240319935884/en/
    Ian Carnelli, Hera’s Project Manager for the European Space Agency attended the delivery event together with the Italian Space Agency, the Milani development team, and numerous local and international dignitaries.
  • Hera Milani is a nanosatellite funded by Italy and developed by Tyvak International for the European Space Agency, devoted to the visual inspection and dust detection of the Didymos asteroid following DART impact.
  • We are eager to see the spacecraft in action and help us unveil the many mysteries around the Didymos asteroid system.”
    The Italian Space Agency and European Space Agency decided to dedicate the Mission to Prof. Andrea Milani, who passed away in 2018.

VTT Info: Aiming for Emission-Free Pulping, Forest Industry and Scientific Community Join Forces

Retrieved on: 
Wednesday, January 17, 2024
University, CO2, University of Oulu, Research, Wood, Business Finland, Aalto University, Chalmers University of Technology, Knowledge, Science, Business, Ecosystem, Biomass, Carbon, Water, LUT University, Stora Enso, University of Helsinki, Emission, Longevity, Mid Sweden University, VTT

The forest industry, technology companies, research organizations, and universities have joined forces to revolutionize the traditional pulping processes under the joint leadership of VTT Technical Research Centre of Finland and RISE Research Institutes of Sweden .

Key Points: 
  • The forest industry, technology companies, research organizations, and universities have joined forces to revolutionize the traditional pulping processes under the joint leadership of VTT Technical Research Centre of Finland and RISE Research Institutes of Sweden .
  • "Due to the limited nature of forest resources, the growth opportunities for the industry are constrained.
  • The key to achieving this lies in fostering innovation and coming together as an industry and as a research ecosystem.
  • This transformation is not just about meeting industry standards; it's about setting new benchmarks for environmental responsibility and operational excellence.

Inside information: Faron Presents Phase 1 Data from BEXMAB in Myeloid Malignancies Trial at the 65th American Society of Hematology (ASH) Annual Meeting

Retrieved on: 
Monday, December 11, 2023
Cellular, Transplant, PR, Efficacy, Principal, Helsinki University Central Hospital, TP53, Standard of care, Nasdaq First North, HMA, Myelodysplastic syndrome, MD Anderson Cancer Center, MD, AIM, Society, MDS, Haematopoietic system, Trial of the century, ASH, University, Faron Pharmaceuticals, University of Helsinki, Safety, Patient, AML, BLA, Vaccine

TURKU, Finland and BOSTON, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON) (“Faron” or the “Company”), a clinical-stage biopharmaceutical company pioneering macrophage reprogramming for effective anticancer immunotherapies, today announced very positive Phase 1 data from the ongoing BEXMAB study in myeloid malignancies, being presented at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition taking place until tomorrow, December 12, 2023, in San Diego, California, and virtually.

Key Points: 
  • “The BEXMAB results continue to improve over time showing remarkable overall response rate in both higher-risk frontline as well as hypomethylating agent (HMA)-failed myelodysplastic syndrome (MDS) patients,” said Dr. Markku Jalkanen, Chief Executive Officer of Faron.
  • "The combination is well-tolerated and generates strong and durable leukemic blast eradication and immune responses.
  • This solidifies bexmarilimab’s unique and leading mechanism of action in the field of myeloid cell re-programming.
  • The data presented at ASH are promising, demonstrating a higher ORR and prolonged response duration in this trial compared to published historical benchmarks.

Young people lifeblood for worldwide ties

Retrieved on: 
Friday, December 8, 2023
Policy, Chemistry, Multimedia, Huanggang Normal University, ADHD, Heart, Friends, China Daily, Child, Personal protective equipment, Conference, University of Helsinki, University, Vanderbilt University, Stamford American International School, Attention deficit hyperactivity disorder, Mask, Doctor of Philosophy, Family, Parent, Spectrum, Education, Shipbuilding, Film industry, Nursing, Video game, Tourism, Science

Representatives of young overseas Chinese participated in the 23rd Conference on Overseas Chinese Pioneering and Developing in China held recently in Wuhan, Hubei province.

Key Points: 
  • Representatives of young overseas Chinese participated in the 23rd Conference on Overseas Chinese Pioneering and Developing in China held recently in Wuhan, Hubei province.
  • We watched Chinese movies, sang Mandarin songs and reminisced about the good times in China.
  • "The Chinese governments at all levels have provided a lot of support for young overseas Chinese entrepreneurs.
  • I believe that overseas Chinese who choose to return to China are determined young people willing to contribute to the development of the motherland."

Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology

Retrieved on: 
Tuesday, October 10, 2023
Neoplasm, Health, Single-cell analysis, University of Helsinki, University, Cancer, Peptide, Ultra, Faculty, EIC, Antigen, Research, Mobile phone, Vaccine, Pharmacy, Bruker

Tumor neoantigens are expressed uniquely by cancer cells and their presence can trigger an efficient immune response against the tumor.

Key Points: 
  • Tumor neoantigens are expressed uniquely by cancer cells and their presence can trigger an efficient immune response against the tumor.
  • Currently the methods available to identify these antigens have significant limitations by being long, complicated and resource demanding.
  • The timsTOF Ultra will be instrumental in the further development and maturation of our PeptiCHIP microfluidic chip technology, supported by the EIC Transition PeptiCHIP grant .
  • We are delighted that, through research collaborations with ValoTx, we can gain access to Bruker’s timsTOF Ultra mass spectrometer.

Altitude Marketing Announces Branding & Marketing Partnership with LS CancerDiag

Retrieved on: 
Thursday, August 10, 2023
Altitude, DNA, MMR, Partnership, Specialization, University, University of Helsinki, Life, B2B, Marketing, Hereditary nonpolyposis colorectal cancer, Cancer, Research, LS, Risk, Diagnosis, Growth, Pharmaceutical industry

EMMAUS, Pa., Aug. 10, 2023 /PRNewswire/ -- LS CancerDiag's ultimate mission is to reduce cancer mortality rates, a mission that's underpinned by a vision for DiagMMR® to become the new global standard test for Lynch syndrome diagnosis. DiagMMR® is a simple and accurate diagnostic method for inherited MMR deficiency, which is linked to Lynch syndrome, the most prevalent inherited cancer predisposition worldwide.

Key Points: 
  • Altitude Marketing, a full-service life sciences marketing and branding agency serving B2B companies for more than 19 years, recently announced a partnership with LS CancerDiag, the distinguished experts behind the groundbreaking DiagMMR® assay.
  • Altitude and LS CancerDiag will embark on a rebranding project to elevate the company's visual and verbal identity.
  • Together, Altitude and LS CancerDiag will embark on a rebranding project to elevate the company's visual and verbal identity.
  • We are honored to have been selected as the company's branding and marketing partner moving forward."

'Is the doggy angry?' Research hints children under 5 can easily confuse dog emotions

Retrieved on: 
Thursday, July 27, 2023
Sound, University of Helsinki, Association, PLOS, Personality, Human, Biting, University, Animal, Emotion, Time, Dog, Hunting, Toy, Entertainment, Vaccine, Animal husbandry

There is perhaps no better species for investigating this idea than the domestic dog.

Key Points: 
  • There is perhaps no better species for investigating this idea than the domestic dog.
  • Adult humans are good at identifying an angry dog visually or by sound, regardless of how much experience they have with dogs.
  • However, young children do not show the same skill, and in fact may mistake a fierce dog for a happy dog.

Rating dog faces

    • It can also help to anticipate them making choices that we as adults would think are an obviously terrible idea when interacting with a dog.
    • In the new study, 34 adults, 34 four-year-olds and 31 six-year-olds were presented with a series of photos of dog faces and human faces.
    • Adults were equally likely to correctly identify dog emotions whether they were experienced or inexperienced with dogs.
    • Children under the age of five are likely to interpret dog expressions by looking for similarities to human expressions.

Supervision is key

    • According to a study from 2001, children 0-4 years in age are the most likely age group to suffer severe dog bites in Australia.
    • Some of those bites may occur as a result of children misunderstanding dog threat displays, and their tendency to lean into dogs when interacting with them.
    • The results suggest children learn to read dogs through experience, but this is occurring at a young age.

ThinkCyte and FIMM Establish Research Partnership to Advance Understanding and Treatment of Blood Cancer

Retrieved on: 
Monday, July 17, 2023
University of Helsinki, Partnership, University, Tumors of the hematopoietic and lymphoid tissues, Bone marrow, Research, Leukemia, Collection, Patient, Artificial intelligence, Diagnosis, Disease

TOKYO, July 17, 2023 /PRNewswire/ -- ThinkCyte today announced a strategic research partnership with the Institute for Molecular Medicine Finland (FIMM-HiLIFE), University of Helsinki aimed at advancing the understanding of leukemia and its treatment.

Key Points: 
  • TOKYO, July 17, 2023 /PRNewswire/ -- ThinkCyte today announced a strategic research partnership with the Institute for Molecular Medicine Finland (FIMM-HiLIFE), University of Helsinki aimed at advancing the understanding of leukemia and its treatment.
  • "Blood cancers are a complex, heterogeneous set of diseases and while the treatment landscape has advanced in recent years, there is still a lot we don't know," said Caroline Heckman, Research Director at FIMM.
  • FIMM hosts the Finnish Hematological Biobank , which is a national biorepository containing an extensive clinical set of leukemia sample series taken at different timepoints of disease and treatment stages (e.g.
  • "We are very excited about the research partnership with FIMM, a global leader in using innovative approaches and technologies to understand and ultimately make a meaningful impact in the lives of patients with blood cancer," said Janette Phi, Chief Business Officer at ThinkCyte.

ChromaDex, a Global Authority on Nicotinamide Adenine Dinucleotide (NAD+), Celebrates the 10th Anniversary of its ChromaDex External Research Program (CERP™), the Industry Leading Research Program Advancing the Science of NAD+ and Healthy Aging

Retrieved on: 
Friday, June 16, 2023
Health, Hospitals, Other Health, General Health, Pharmaceutical, Vitamins, Supplements, Biotechnology, University of Helsinki, Science, Human, Cell Metabolism, University, PD, Heart failure, Metabolism, CERP, Science Advances, NR, Placebo, LVEF, Spinal cord, Research fellow, Clinical trial, Ageing, NAD, University of Oslo, Philip Morris External Research Program, ChromaDex, Research, Brain, Inflammation, Affiliation, Mitochondrion, DSM-IV codes, University of Washington School of Medicine, Trial of the century, Associate, Haukeland University Hospital, University of Bergen, City, Publication, Parkinson's disease, Patient, Division, Heart, University of Copenhagen Faculty of Health and Medical Sciences, University of Oulu, Diabetes, Safety, Copenhagen, Dietary supplement, Pharmaceutical industry, Medical device, Nicotinamide riboside, Cardiology

On June 13th, ChromaDex Corp. (NASDAQ:CDXC), a global authority on nicotinamide adenine dinucleotide (NAD+) research and healthy aging, celebrated the 10th anniversary of its award-winning ChromaDex External Research Program (CERP™).

Key Points: 
  • On June 13th, ChromaDex Corp. (NASDAQ:CDXC), a global authority on nicotinamide adenine dinucleotide (NAD+) research and healthy aging, celebrated the 10th anniversary of its award-winning ChromaDex External Research Program (CERP™).
  • On behalf of the ChromaDex family, we are thrilled to commemorate our ChromaDex External Research Program as it celebrates a decade of setting the industry standard for excellence in collaborative research,” said Rob Fried, the CEO of ChromaDex.
  • This approach fosters great trust in the research, as often there is skepticism around industry-funded research in the dietary supplement industry.
  • Today, this unique, industry-leading program has research agreements with over 200 institutions in 31 countries, representing over $95 million in estimated total research value.

CAE Expands Critical Thinking Skills Collaboration With Finland Ministry of Education and Culture

Retrieved on: 
Wednesday, May 31, 2023
University of Helsinki, CAE, Problem solving, University, Stockmann, Helsinki centre, Lagos University Teaching Hospital, Curriculum, Policy, BBB National Programs, Research, Educational research, Student, Council, Culture, Collegiate Learning Assessment, Collegiate, Nursing, Management, Learning, Education

NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- The Council for Aid to Education, Inc. (CAE), a leader in designing innovative performance tasks for measurement and instruction of higher order skills, today announced a multiyear collaboration with the Finland Ministry of Education and Culture, expanding on a previous study that measured Finnish higher education students’ critical thinking, problem solving, and written communication skills (“generic skills”).

Key Points: 
  • NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- The Council for Aid to Education, Inc. (CAE), a leader in designing innovative performance tasks for measurement and instruction of higher order skills, today announced a multiyear collaboration with the Finland Ministry of Education and Culture, expanding on a previous study that measured Finnish higher education students’ critical thinking, problem solving, and written communication skills (“generic skills”).
  • “CAE is honored that the Finland Ministry of Education and Culture has again chosen our assessments to gain a deeper understanding of the level of generic skills and the factors that can improve these skills for their higher education students,” said Bob Yayac, CAE president and chief executive officer.
  • “Critical thinking and communication skills are essential for academic and career success, whether in Finland or throughout the international community,” said Dr. Jani Ursin, co-national program manager, University of Jyväskylä Finnish Institute for Educational Research (FIER).
  • “It is our responsibility to provide higher education institutions the tools they need to support student success,” said Maarit Palonen, counsellor of education, Finland Ministry of Education and Culture.